tiprankstipranks
Trending News
More News >
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Compare Vir Biotechnology (VIR) vs. Competitors

Compare
1,463 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vir Biotechnology
$6.82
$948.83M
-1.88
-33.30%
8 Buy
0 Hold
0 Sell
Strong Buy
Xencor
$14.45
$1.03B
-24.39%
10 Buy
1 Hold
0 Sell
Strong Buy
Iovance Biotherapeutics
$2.38
$944.78M
-1.98
-59.59%
6 Buy
1 Hold
1 Sell
Moderate Buy
Anavex Life Sciences
$4.82
$430.66M
-8.86
-53.96%
1 Buy
1 Hold
0 Sell
Moderate Buy
Inventiva
$5.98
$1.13B
-1.47
183.28%
6 Buy
0 Hold
0 Sell
Strong Buy
Septerna, Inc.
$26.73
$1.20B
-17.70
57.61%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VIR
Vir Biotechnology
6.82
-3.23
-32.14%
XNCR
Xencor
14.45
-5.58
-27.86%
IOVA
Iovance Biotherapeutics
2.38
-3.38
-58.68%
AVXL
Anavex Life Sciences
4.82
-5.33
-52.51%
IVA
Inventiva
5.98
3.82
176.85%
SEPN
Septerna, Inc.
26.73
9.75
57.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts